SEC Form 4 · accession 0001179110-16-030835
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Krop
Officer — SVP Clinical & Regulatory, CMO
Period of report
Oct 20, 2016
Accepted (ET)
Oct 20, 2016 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 20, 2016 | S | 4,938 | $24.80 | D | 23,668 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2016.